ProQR Therapeutics (PRQR) Capital Expenditures Growth (3y) (2016 - 2025)
ProQR Therapeutics (PRQR) Capital Expenditures Growth (3y) (2016 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
- |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
46.88% |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
- |
| 10 |
ProQR Therapeutics |
7.27 Mn |
-100.30 Mn |
- |
6.53% |
| Date | Value |
|---|
| Dec 31, 2025 |
6.53% |
| Sep 30, 2025 |
7.30% |
| Jun 30, 2025 |
22.59% |
| Mar 31, 2025 |
4.89% |
| Dec 31, 2024 |
136.46% |
| Sep 30, 2024 |
-15.03% |
| Jun 30, 2024 |
-66.21% |
| Mar 31, 2024 |
-174.14% |
| Dec 31, 2023 |
163.84% |
| Sep 30, 2023 |
-6.17% |
| Jun 30, 2023 |
5.46% |
| Mar 31, 2023 |
-774.09% |
| Dec 31, 2022 |
95.84% |
| Sep 30, 2022 |
-90.98% |
| Jun 30, 2022 |
-36.63% |
| Mar 31, 2022 |
-2.61% |
| Dec 31, 2021 |
-1,928.92% |
| Sep 30, 2021 |
-21.47% |
| Jun 30, 2021 |
33.94% |
| Mar 31, 2021 |
-1,888.00% |
